Serum Irisin in Myocardial Infraction and Following Percutaneous Coronary Intevention

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 116 participants.

Also called NCT02498431

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 116 participants (enrolled count) (from the registry)
Sponsor
424 General Military Hospital (from the registry)
Registry
  • NCT NCT02498431
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Greece (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02498431. Non-randomized; no masking; primary purpose diagnostic. Start 2015-06 (registry gives no type); primary completion 2015-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Serum Irisin in Myocardial Infraction and Following Percutaneous Coronary Intevention
Acronym
IRICARDIO
Intervention (Procedure)
percutaneous coronary intervention
Intervention (Procedure)
coronary angiography
Intervention (Device)
Stent, Medronic Resolute Integrity
Lead sponsor
424 General Military Hospital (class: other)

Record details

Record id
cardio:ct-nct02498431
Content hash
74e865460b4becd3a9d0a3f0089d090ed8d34d66ab661651d6741710f01ae95a